APA

Burmeister B. H., Michael M., Burmeister E., Cox S., Lehman M., Wirth A., Horwood K., Sasso G., Forouzesh B. & Ball D. (20120411). A randomized phase II trial of two regimens of moderate dose chemoradiation therapy for patients with non-small cell lung cancer not suitable for curative therapy: Trans Tasman Radiation Oncology Study TROG 03.07. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Chicago

Burmeister Bryan H, Michael Michael, Burmeister Elizabeth, Cox Sharon, Lehman Margot, Wirth Andrew, Horwood Keith, Sasso Giuseppe, Forouzesh Barham and Ball David. 20120411. A randomized phase II trial of two regimens of moderate dose chemoradiation therapy for patients with non-small cell lung cancer not suitable for curative therapy: Trans Tasman Radiation Oncology Study TROG 03.07. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Harvard

Burmeister B. H., Michael M., Burmeister E., Cox S., Lehman M., Wirth A., Horwood K., Sasso G., Forouzesh B. and Ball D. (20120411). A randomized phase II trial of two regimens of moderate dose chemoradiation therapy for patients with non-small cell lung cancer not suitable for curative therapy: Trans Tasman Radiation Oncology Study TROG 03.07. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

MLA

Burmeister Bryan H, Michael Michael, Burmeister Elizabeth, Cox Sharon, Lehman Margot, Wirth Andrew, Horwood Keith, Sasso Giuseppe, Forouzesh Barham and Ball David. A randomized phase II trial of two regimens of moderate dose chemoradiation therapy for patients with non-small cell lung cancer not suitable for curative therapy: Trans Tasman Radiation Oncology Study TROG 03.07. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 20120411.